DrugManagementForum.com

FDA Safety Changes: Levaquin, NovoLog, Zevalin

This is a discussion on FDA Safety Changes: Levaquin, NovoLog, Zevalin within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; The FDA has approved revisions to the safety labeling for levofloxacin (Levaquin), insulin aspart [rDNA origin] injection (NovoLog), and ibritumomab ...


Go Back   DrugManagementForum.com > Industry News and Updates > Other Clinical Pharmacy News

Register Help Members List Mark Forums Read

Rate This Thread - FDA Safety Changes: Levaquin, NovoLog, Zevalin.

Only registered members can vote. To rate this thread register here.

Reply

 

Thread Tools
  #1 (permalink)  
Old 08-14-2008, 12:37 AM
automated news aggregator
 
Join Date: Jan 2008
Posts: 1,083
Default FDA Safety Changes: Levaquin, NovoLog, Zevalin

The FDA has approved revisions to the safety labeling for levofloxacin (Levaquin), insulin aspart [rDNA origin] injection (NovoLog), and ibritumomab tiuxetan injection (Zevalin).
Medscape Medical News

More...
Reply With Quote
Reply


Thread Tools
Display Modes



© 2008 DrugManagementForumpowered by
Informaceutica - Drug Management Information Company

All times are GMT -4. The time now is 11:34 PM.